Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2012
10/10/2012CN101287988B Methods and compositions for diagnosis and treatment of influenza
10/10/2012CN101274932B 2-methyl-5- azomycin-1-(3-chloro-2-hydroxypropyl) chloro-substitutive derivate, preparation thereof and application thereof
10/10/2012CN101229127B Liposome preparation
10/10/2012CN101128215B Immunogenic composition for use in vaccination against staphylococcei
10/10/2012CN101115765B Modified 5'-phosphonates of azt potential antiviral drugs
10/10/2012CN101057975B Cocktail vaccine for anti immune tolerance and immunodeficiency virus and its application
10/09/2012US8283462 Group of nucleic acid fragments for prevention of HIV infection or AIDS and the usage thereof
10/09/2012US8283363 Carboxamide compounds and their use as calpain inhibitors
10/09/2012US8283321 Kallikrein-binding “Kunitz domain” proteins and analogues thereof
10/09/2012US8283164 Liver engrafting cells, assays, and uses thereof
10/09/2012US8282935 Intensify immunology response; administering epitopes; polynucleotide sequences
10/09/2012US8282933 genetic engineered proteins useful as immunogens in vaccines; prevention of periodontal disease
10/09/2012CA2747845C Compositions and methods for dermally treating pain
10/09/2012CA2668997C 4-cyanophenylamino-substituted bicyclic heterocyclic compounds as hiv inhibitors
10/09/2012CA2633516C Elongase genes and uses thereof
10/09/2012CA2550598C Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method and their use in therapy
10/09/2012CA2535926C N,n-dihalogenated amino acids and derivatives
10/09/2012CA2494197C Streptococcus uberis protein, nucleic acid sequence encoding the same and its use in a mastitis vaccine
10/09/2012CA2480389C Modified saccharides having improved stability in water
10/09/2012CA2476901C Anti-ccr5 antibody
10/09/2012CA2466474C Compositions comprising spa-1, spa-2 and spa-3, polypeptides and related uses
10/09/2012CA2459347C Locked nucleic acid (lna) compositions and uses thereof
10/09/2012CA2451040C Gum resin for topical administration of pharmacologically active agents
10/09/2012CA2358517C Method and composition for angiogenesis inhibition
10/09/2012CA2164698C Synthetic peptide inhibitors of hiv transmission
10/04/2012WO2012135615A2 Enopeptins, uses thereof, and methods of synthesis thereto
10/04/2012WO2012135296A2 Imidazolyl amide compounds and uses related thereto
10/04/2012WO2012135177A2 Methods and compositions for cytomegalovirus il-10 protein
10/04/2012WO2012135133A1 Lipoxygenase inhibitors
10/04/2012WO2012135132A1 Compositions and methods to immunize against hepatitis c virus
10/04/2012WO2012135112A2 Methods for preparing deuterated 1,2,3-triazoles
10/04/2012WO2012135027A2 Thiolactone antibiotics
10/04/2012WO2012134351A1 Clathrate complexes of beta-cyclodextrin and 5-hydroxy-4-aminomethyl-1-cyclohexyl (or cycloheptyl)-3-alkoxycarbonyl indole derivative, which exhibit an anti-viral effect, and methods for producing said complexes
10/04/2012WO2012134188A2 Novel oxazolidinone derivative and medical composition containing same
10/04/2012WO2012134184A2 Novel cephalosporin derivative and medical composition containing same
10/04/2012WO2012133827A1 Novel lactic acid bacterium, and pharmaceutical, food or drink, and feed, each containing novel lactic acid bacterium
10/04/2012WO2012133735A1 Nucleic acid construct containing nucleic acid derived from genotype 1b hcv genome, hcv genome-replicating cells transfected with same, and method for producing infectious hcv particles
10/04/2012WO2012133648A1 Novel preparation technique for higher-order structure that exhibits anti-cellular effect
10/04/2012WO2012133198A1 Nutritional composition for inflammatory diseases
10/04/2012WO2012132913A1 Clostridium difficile growth inhibitor
10/04/2012WO2012131732A1 A synergistic herbal extract composition for use in treating and preventing mastitis
10/04/2012WO2012131723A1 A herbal formulation to treat mastitis in animals
10/04/2012WO2012131714A1 Veterinary herbal compositions and medicaments thereof
10/04/2012WO2012131650A1 Herbal compositions of coccinia indica for treatment or prevention of inflammatory diseases
10/04/2012WO2012131588A1 3-ureidoisoquinolin-8-yl derivatives
10/04/2012WO2012131396A1 3 -descladinosyl-o- carbamoyl functionalized derivatives of azithromycin
10/04/2012WO2012131377A1 Macrocyclic compounds and methods for their production
10/04/2012WO2012131371A1 Macrocyclic compound and methods for its production
10/04/2012WO2012131134A1 Use of a non-coding region of the genome of the foot-and-mouth virus for the purpose of producing an antiviral drug
10/04/2012WO2012131128A1 Diva method for differentiating animals vaccinated against brucellosis
10/04/2012WO2012131061A1 Treatment for infection with hepatitis b virus alone or in combination with hepatitis delta virus and associated liver diseases
10/04/2012WO2012130996A1 Alisporivir to treat hepatitis c virus infection
10/04/2012WO2012130893A1 Use of epigallocatechin gallate as an antiviral agent against infections by the hepatitis c virus
10/04/2012WO2012130862A1 Selection of hcv treatment
10/04/2012WO2012130609A1 New combination comprising n-acetyl-l-cysteine and its use
10/04/2012WO2012130114A1 Screening model for blockers of interaction between ribosomal proteins l12 and l10 of tubercle bacillus and use thereof
10/04/2012WO2012129957A1 Several pharmaceutical formulations
10/04/2012WO2012129949A1 Use of traditional chinese medicine composition in preparation of anti-enterovirus 71 drug
10/04/2012WO2012129645A1 Non-pathogenic serotype 4 fowl adenovirus (fadv-4) and viral vector thereof
10/04/2012WO2012087004A3 Use of upr signaling pathway genes ire1 and hxl1 for treatment of fungal infection and meningitis
10/04/2012WO2012083445A8 Virus like particle production in plants
10/04/2012WO2012036585A8 Pharmaceutical composition with antimicrobial activity for parenteral administration and process for preparing same
10/04/2012WO2010039548A3 Chemical modifications of monomers and oligonucleotides with cycloaddition
10/04/2012US20120255045 Inducible small rna expression constructs for targeted gene silencing
10/04/2012US20120253312 Prevention of Infection
10/04/2012US20120252890 Process and compounds for the manufacture of oseltamivir and analogs thereof, and new antiviral agents
10/04/2012US20120252874 Methods for delivery of sirna to the spinal cord and therapies arising therefrom
10/04/2012US20120252869 Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt)
10/04/2012US20120252864 Substituted isoindoline-1,3-dione derivatives
10/04/2012US20120252847 Novel form of s-omeprazole
10/04/2012US20120252846 Buccal, polar and non-polar spray or capsule containing drugs for treating pain
10/04/2012US20120252837 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof
10/04/2012US20120252834 Novel use and method of rapamycin to treat toxic shock
10/04/2012US20120252824 Drug Combinations and Uses in Treating a Coughing Condition
10/04/2012US20120252820 Methods of treating fungal infections
10/04/2012US20120252817 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES
10/04/2012US20120252807 Arbovirus inhibitors and uses thereof
10/04/2012US20120252801 Antifungal compounds
10/04/2012US20120252799 Heterocyclic aromatic compounds useful as growth hormone secretagogues
10/04/2012US20120252798 Indole compounds as an inhibitor of cellular necrosis
10/04/2012US20120252790 Amino-Derivatives As Novel Inhibitors Of Histone Deacetylase
10/04/2012US20120252778 Pyrazolo pyrimidine derivatives
10/04/2012US20120252755 Compositions and methods for disinfecting materials
10/04/2012US20120252752 Compositions, methods and kits for repressing virulence in gram positive bacteria
10/04/2012US20120252751 Anti-viral nucleoside analogs and methods for treating viral infections, especially hiv infections
10/04/2012US20120252747 Macrocyclic compounds and methods of making and using the same
10/04/2012US20120252742 Human Single-Chain T Cell Receptors
10/04/2012US20120252741 Novel semi-synthetic glycopeptides as antibacterial agents
10/04/2012US20120252740 Hdac inhibitors and therapeutic methods of using same
10/04/2012US20120252732 Albumin fusion proteins
10/04/2012US20120252723 Regulating the Amino Acid Pool Used for the Acute-Phase Protein Synthesis
10/04/2012US20120252722 Metal-binding therapeutic peptides
10/04/2012US20120252721 Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
10/04/2012US20120252720 Compositions for treatment of ear disorders and methods of use thereof
10/04/2012US20120251625 Use of extract of leeches as anti-bacterial agent
10/04/2012US20120251616 Tocopherols, Tocotrienols, Other Chroman and Side Chain Derivatives and Uses Thereof
10/04/2012US20120251607 Antimicrobial compositions, methods of preparation thereof, and uses thereof
10/04/2012US20120251595 Emulsion template method to form small particles of hydrophobic agents with surface enriched hydrophilicity by ultra rapid freezing
10/04/2012US20120251594 Delivery of Submicrometer and Nanometer Aerosols to the Lungs Using Hygroscopic Excipients or Dual Stream Nasal Delivery
10/04/2012US20120251585 Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
1 ... 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 ... 1798